2024
Attributes of higher- and lower-performing hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) program implementation: A multiple-case study
Stevens E, Fawole A, Rostam Abadi Y, Fernando J, Appleton N, King C, Mazumdar M, Shelley D, Barron C, Bergmann L, Siddiqui S, Schatz D, McNeely J. Attributes of higher- and lower-performing hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) program implementation: A multiple-case study. Journal Of Substance Use And Addiction Treatment 2024, 168: 209528. PMID: 39343141, PMCID: PMC11624095, DOI: 10.1016/j.josat.2024.209528.Peer-Reviewed Original ResearchLower-performing hospitalsOpioid use disorderStepped-wedge cluster randomized controlled trialCluster randomized controlled trialGeneral careHigher-performing hospitalsNew York City's public hospital systemOpioid use disorder treatment programsHigh-performing hospitalsPublic hospital systemAddiction consult servicesPost-discharge medicationUse disorderMultiple-case study designAddiction treatmentRandomized controlled trialsProvider staffingFacility characteristicsHospital systemIndicators of awarenessImplementation periodProgram implementationStudy designCareBuy-inSelf-Reported Methamphetamine Use Versus Biological Testing Among Treatment-Seeking Patients
Gholami J, Ardeshir M, Rostam-Abadi Y, Baheshmat S, Shadloo B, Rahimi-Movaghar A. Self-Reported Methamphetamine Use Versus Biological Testing Among Treatment-Seeking Patients. Iranian Journal Of Psychiatry And Behavioral Sciences 2024, 18 DOI: 10.5812/ijpbs-148330.Peer-Reviewed Original ResearchNegative predictive valuePositive percent agreementMethamphetamine use disorderMethamphetamine useTreatment-seeking patientsSelf-reported useCohen's kappa statisticUrine testsUse disorderPercent agreementKappa statisticNo significant factorsCross-sectional studyDrug treatment centersMonitoring treatmentPredictive valueMethamphetaminePatientsImmunoassay techniqueTreatment-seekingTreatment centersUrinalysisUrineAddiction studiesTreatmentAn exploratory study of the prevalence and adverse associations of in-school traditional bullying and cyberbullying among adolescents in Connecticut
Rostam-Abadi Y, Stefanovics E, Zhai Z, Potenza M. An exploratory study of the prevalence and adverse associations of in-school traditional bullying and cyberbullying among adolescents in Connecticut. Journal Of Psychiatric Research 2024, 173: 372-380. PMID: 38593696, DOI: 10.1016/j.jpsychires.2024.03.033.Peer-Reviewed Original ResearchConceptsBullying statusPatterns of bullyingAnti-bullying interventionsYouth Risk Behavior Survey dataInfluence of alcoholTraditional bullyingBullying subgroupsWeapon-carryingDating violenceBehavior Survey dataAssociated with suicide attemptsBullyingReport bullyingMental healthPhysical fightingSelf-harmHigh school studentsCyberbullyingReceipt of social supportConnecticut high school studentsSurvey-weighted logistic regressionAcademic performanceLogistic regressionInsecure housingPerceived family supportAlcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review
Rostam‐Abadi Y, Gholami J, Shadloo B, Aghaei A, Jobehdar M, Ardeshir M, Sangchooli A, Amin‐Esmaeili M, Taj M, Saeed K, Rahimi‐Movaghar A. Alcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review. Addiction 2024, 119: 984-997. PMID: 38356084, DOI: 10.1111/add.16444.Peer-Reviewed Original ResearchConceptsAdult general populationGeneral populationAlcohol useEastern Mediterranean RegionWorld Health OrganizationAlcohol use disorderPrevalence of alcohol use disordersYoung general populationHealth OrganizationEastern Mediterranean countriesPatterns of alcohol usePublic health impactUse disorderHeavy episodic drinkingEstimates of alcoholAlcohol consumptionPooled prevalencePooled estimatesSystematic reviewHealth impactsEpisodic drinkingHeavy drinkingSubstance useTreatment-seeking peoplePrevalence
2023
Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys
Ebrahimi H, Masinaei M, Aminorroaya A, Aryan Z, Mehdipour P, Rostam-Abadi Y, Ahmadi N, Moghaddam S, Pishgar F, Ghanbari A, Rezaei N, Takian A, Farzadfar F. Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys. PLOS ONE 2023, 18: e0290006. PMID: 37611004, PMCID: PMC10446220, DOI: 10.1371/journal.pone.0290006.Peer-Reviewed Original ResearchConceptsCardiovascular disease riskRisk of cardiovascular diseaseNon-communicable disease risk factor surveillanceCardiovascular diseaseCVD riskWorld Health OrganizationRisk of incident cardiovascular diseaseRisk factor surveillanceFramingham 10-year CVD riskAdult Iranian populationIncident cardiovascular diseaseRisk factor modificationCardiovascular disease risk stratificationEvidence-based decisionsFramingham modelHealth policyNationally representative datasetFactor modificationRisk estimation modelIranian populationHealth OrganizationFraminghamSurvey's backgroundRiskSubnational levelPrevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis
Aghaei A, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis. The Lancet Global Health 2023, 11: e1225-e1237. PMID: 37474230, DOI: 10.1016/s2214-109x(23)00267-x.Peer-Reviewed Original ResearchConceptsPrevalence of injection drug useInjection drug usePrevalence of HIVHepatitis B virusHepatitis C virusB virusC virusMeta-analysisSystematic reviewHepatitis C virus infection ratesEastern Mediterranean RegionCharacteristics of peopleDrug useHIV infection ratesOpioid agonist treatmentInfection rateProgramme servicesPopulation size of peopleHepatitis CAgonist treatmentHarm reduction servicesHepatitis BWHO Eastern Mediterranean RegionWeb of ScienceProvision of servicesSix-Year Follow-up of People Who Use Methamphetamine in Iran: A Case Series Study
Mohammad Aghaei A, Gholami J, Amin-Esmaeili M, Baheshmat S, Rostam-Abadi Y, Rahimi-Movaghar A. Six-Year Follow-up of People Who Use Methamphetamine in Iran: A Case Series Study. International Journal Of High Risk Behaviors And Addiction 2023, 12 DOI: 10.5812/ijhrba-131659.Peer-Reviewed Original ResearchMethamphetamine useIranian Mental Health SurveyFollow-up of peopleSubstance use treatment servicesMental Health SurveyCase series studyFrequency of methamphetamine useHealth care treatmentSix-year follow-upUse disorderSeries studyMethamphetamine use disorderHealth SurveyCompleted interviewsAdverse eventsStudy participantsTreatment servicesEligible casesRate of adverse eventsCare treatmentParticipantsProspective studyTwo-thirdsIncidence of adverse eventsInterviewsDrug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review
Rostam-Abadi Y, Gholami J, Jobehdar M, Ardeshir M, Aghaei A, Olamazadeh S, Taj M, Saeed K, Mojtabai R, Rahimi-Movaghar A. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. The Lancet Psychiatry 2023, 10: 282-295. PMID: 36848914, DOI: 10.1016/s2215-0366(22)00435-7.Peer-Reviewed Original ResearchConceptsDrug use disordersEastern Mediterranean RegionDrug useTreatment servicesUse disorderIncreasing global public health concernCost-effective carePrevalence of drug use disordersGlobal public health concernPublic health concernPrevalence of drug useGrey literaturePatterns of drug useOpioid agonist treatmentEvidence-basedSystematic reviewTreatment coverageHealth concernAgonist treatmentRegional levelYoung peoplePrevalenceOnline databasesDrugLimited dataA Six-Year Follow-up of People Who Use Cannabis in Iran – A Case Series
Rostam-Abadi Y, Amin-Esmaeili M, Baheshmat S, Aghaei A, Gholami J, Rahimi-Movaghar A. A Six-Year Follow-up of People Who Use Cannabis in Iran – A Case Series. Addiction And Health 2023, 15: 71-76. PMID: 37560074, PMCID: PMC10408741, DOI: 10.34172/ahj.2023.1357.Peer-Reviewed Original ResearchCannabis useFrequency of cannabis useSample of cannabis usersFrequent cannabis useMental Health SurveyIranian Mental Health SurveyEligible individualsAssociated with adverse health-related outcomesCannabis usersAdverse event statusAdverse health-related outcomesSix-year follow-upAdverse eventsFollow-up of peopleHealth-related outcomesCannabisHealth SurveyVital statusTelephone callsIndex surveyBaseline statusIndividualsParticipantsAbstinenceEvent status
2022
Loneliness in the presence of others: A mixed-method study of social networks of caregivers of patients with severe mental disorders
Tabatabaee M, Nooraie R, Aghaei A, Rostam-Abadi Y, Ansari M, Sharifi S, Sharifi V. Loneliness in the presence of others: A mixed-method study of social networks of caregivers of patients with severe mental disorders. International Journal Of Social Psychiatry 2022, 69: 190-199. PMID: 35148620, DOI: 10.1177/00207640221077580.Peer-Reviewed Original ResearchConceptsCaregivers of patientsPersonal support networksImmediate family membersSupport networksMental disordersSevere mental illnessNetwork of caregiversFamily membersSource of family distressMiddle-income countriesMixed-methods designMixed-methods studySevere mental disordersCaregiver networkCaregiver supportMental illnessFamily distressEmotional supportCaregiversSocioeconomic variablesPerceived needStigmaParticipantsSocial relationshipsSystem supportMortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study
Gholami J, Baheshmat S, Rostam‐Abadi Y, Hamzehzadeh M, Mojtabai R, Rahimi‐Movaghar A, Amin‐Esmaeili M. Mortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study. Addiction 2022, 117: 2059-2066. PMID: 35037359, DOI: 10.1111/add.15805.Peer-Reviewed Original ResearchConceptsComposite International Diagnostic InterviewOutcomes of opioid use disorderOpioid use disorderOpioid useDeath registration systemFollow-up studyWeighted incidence rateMiddle-income countriesAdverse outcomesNegative consequences of opioid useUse disorderFollow-up interviewsCohort of individualsOutcomes of opioid useConsequences of opioid useHealth outcomesFollow-upVital statusAssociated with increased mortalityTelephone callsDiagnostic InterviewRegistration systemPopulation-wereDeath rateHousehold surveyPrevalence, pattern, and associated factors of alcohol use disorder among male treatment-seeking people with illicit drug use disorder in Tehran, Iran
Rafiemanesh H, Rahimi-Movaghar A, Shadloo B, Rostam-Abadi Y, Nedjat S, Yazdani K. Prevalence, pattern, and associated factors of alcohol use disorder among male treatment-seeking people with illicit drug use disorder in Tehran, Iran. Journal Of Substance Use 2022, 28: 211-216. DOI: 10.1080/14659891.2021.2020346.Peer-Reviewed Original ResearchAlcohol use disorderIllicit drug use disordersFactors of alcohol use disorderDrug use disordersUse disorderComorbid alcoholLifetime prevalence of alcohol dependenceAlcohol dependencePrevalence of alcohol use disordersAssociated with alcohol use disorderAssess alcohol use disorderHazardous useResidential drug treatment centerPrevalence of alcohol dependenceLogistic regression analysisMultivariate regression analysisComposite International Diagnostic InterviewCross-sectional studyRegression analysisMale patientsTreatment-seeking peopleDrug treatment centersAlcohol moduleTreatment-seeking individualsLifetime prevalence
2021
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M, Vahdani B, Ekhtiari H, Mojtabai R, Rahimi-Movaghar A. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal Of Drug Policy 2021, 100: 103529. PMID: 34826790, DOI: 10.1016/j.drugpo.2021.103529.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentNon-prescribed useMethadone useSystematic reviewGeneral populationPositive health outcomesUse disorderFemale general populationSystematic review of studiesSixty-five studiesRandom-effects modelLegal Medicine OrganizationMethadone maintenance treatment programsPublic health concernHealth outcomesSubstance-related deathsReview of studiesPooled proportionCases of acute poisoningMaintenance treatmentMedicine organizationsDrug treatment centersIranian databasesAdverse outcomesPrescription opioidsHIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis
Gholami J, Rostam‐Abadi Y, Rahimi Y, Fotouhi A, Amin‐Esmaeili M, Rahimi‐Movaghar A. HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis. Drug And Alcohol Review 2021, 41: 666-676. PMID: 34783411, DOI: 10.1111/dar.13407.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus prevalenceHuman immunodeficiency virusOdds of HIV infectionHIV infectionSystematic reviewPrevalence of human immunodeficiency virusPrevalence of HIV infectionReduce HIV prevalenceRandom-effects modelCitation trackingHIV prevalenceImmunodeficiency virusNo significant differenceHarm reductionPWUDGeneral populationUnpublished studiesGender subgroupsComprehensive searchNational databaseMeta-analysisSignificant differencePrevalencePreventive measuresInfectionEvidence for an increase in cannabis use in Iran – A systematic review and trend analysis
Rostam-Abadi Y, Gholami J, Amin-Esmaeili M, Baheshmat S, Hamzehzadeh M, Rafiemanesh H, Nasserbakht M, Ghalichi L, Safarcherati A, Taremian F, Mojtabai R, Rahimi-Movaghar A. Evidence for an increase in cannabis use in Iran – A systematic review and trend analysis. PLOS ONE 2021, 16: e0256563. PMID: 34460847, PMCID: PMC8404985, DOI: 10.1371/journal.pone.0256563.Peer-Reviewed Original ResearchConceptsCannabis use disorderCannabis useUse disorderPrevalence of cannabis use disorderTrends of cannabis usePrevalence of cannabis useGeneral populationPrevalence estimatesHigh-risk groupIranian general populationRandom-effects modelPooled prevalence estimatePooled prevalenceYouth groupsCannabisA systematic reviewSex subgroupsIllicit substancesIranian databasesPrevalenceSystematic reviewNational studyFemale university studentsDisordersMaleDiscrimination in COVID-19 vaccination programs – A possible risk for mental health
Ansari M, Mohammad Aghaei A, Rezaie Y, Rostam-Abadi Y. Discrimination in COVID-19 vaccination programs – A possible risk for mental health. Asian Journal Of Psychiatry 2021, 63: 102758. PMID: 34271537, PMCID: PMC8268669, DOI: 10.1016/j.ajp.2021.102758.Peer-Reviewed Original ResearchBuprenorphine abuse and health risks in Iran: A systematic review
Ansari M, Rostam-Abadi Y, Baheshmat S, Hamzehzadeh M, Gholami J, Mojtabai R, Rahimi-Movaghar A. Buprenorphine abuse and health risks in Iran: A systematic review. Drug And Alcohol Dependence 2021, 226: 108871. PMID: 34214882, DOI: 10.1016/j.drugalcdep.2021.108871.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance treatmentSystematic reviewPrevalence of non-prescribed useNon-prescribed useInternational electronic databasesBuprenorphine poisoningCompared to other opioidsBuprenorphine useElectronic databasesPoisoning casesIdentified recordsDrug poisoning casesIranian databasesGeneral populationEligibility criteriaTreatment-seekingNational studyRegular useNon-prescribed buprenorphine useMaintenance treatmentBuprenorphineHealth risksBuprenorphine abusePrevalenceRelevant dataComparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder
Shadloo B, Baheshmat S, Rostam-Abadi Y, Shakeri A, Gholami J, Rahimi-Movaghar A. Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder. Journal Of Substance Use And Addiction Treatment 2021, 134: 108555. PMID: 34210569, DOI: 10.1016/j.jsat.2021.108555.Peer-Reviewed Original ResearchConceptsOpioid use disorderSelf-reported opioid useOpioid usePositive percent agreementUrine testsTreatment-seeking patientsCohen's kappa statisticPercent agreementUse disorderKappa statisticNegative predictive valueLonger treatment durationMonitoring treatment adherenceRandom urine testingResults of urinalysisValidity of self-reported drug useCross-sectional studySelf-reported substance useSelf-reported drug useTreatment durationOpioidPredictive valuePatientsTreatment adherenceDrug useThe immune system and autism spectrum disorder: association and therapeutic challenges
Heidari A, Rostam–Abadi Y, Rezaei N. The immune system and autism spectrum disorder: association and therapeutic challenges. Acta Neurobiologiae Experimentalis 2021, 81: 249-263. PMID: 34672295, DOI: 10.21307/ane-2021-023.Peer-Reviewed Original ResearchConceptsCentral nervous systemPlasma levels of pro-inflammatory cytokinesPrevalence of autoimmune disordersImmune systemLevels of pro-inflammatory cytokinesFirst-degree family membersAutism spectrum disorderPro-inflammatory cytokinesAnti-inflammatory drugsInnate immune systemDevelopment of autism spectrum disorderAutoimmune involvementDefinitive treatmentAutoimmune processAutoimmune disordersImmunological factorsPlasma levelsGut-brain axisTriggering inflammationASD patientsHighest prevalenceNervous systemPathogenesisASD pathogenesisGenetic factors
2020
Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment
Meimand S, Rostam-Abadi Y, Rezaei N. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment. Expert Review Of Clinical Immunology 2020, 17: 27-35. PMID: 33191807, DOI: 10.1080/1744666x.2020.1850273.Peer-Reviewed Original ResearchConceptsNK cellsNatural killer (NK) cellsReceptors of NK cellsImmune systemNK cell dysfunctionNatural killer cellsPathogenesis of autism spectrum disorderNeurodevelopmental disordersImproper immune responsesInnate immune systemImmune abnormalitiesImmune therapyImmune dysregulationKiller cellsAutism spectrum disorderTreatment optionsImmune regulationCell dysfunctionImmune responseImmune functionCytotoxic featuresSpectrum disorderEarly-onset impairmentDisordersPathogenesis